Sign In
Get Clay Free →

Suggestions

    Sam Ifergan

    Founder and Managing Partner - iGan Partners #HealthcareDisruptor #VC

    Sam Ifergan is a prominent figure in the healthcare and venture capital sectors, serving as the Chairman of the Board at Rna Diagnostics Inc. He is also the Founder and Managing Partner of iGan Partners, a leading healthcare venture capital firm in Canada. With over 25 years of experience in entrepreneurship, technology, and venture capital, Ifergan has played a significant role in supporting the commercialization of innovative medical technologies.

    Professional Background

    • Education: Ifergan holds a Bachelor of Electrical Engineering from McGill University and an MBA from the John Molson School of Business.
    • Career Highlights:
      • He founded iGan Partners in 2013, which has become the largest healthcare venture capital investor in Canada. The firm has supported over 25 successful medical device and digital health companies.
      • Prior to establishing iGan, he co-founded several tech companies, including Visual Sonics (acquired by Fuji Medical) and Tri-Link Technologies (acquired by Teltronics) .12

    Role at Rna Diagnostics

    At Rna Diagnostics Inc., Ifergan oversees strategic initiatives aimed at enhancing cancer treatment through innovative diagnostic solutions. The company focuses on developing the RNA Disruption Assay™, which helps oncologists assess patient responses to chemotherapy early in treatment, thereby optimizing therapeutic strategies .23

    Contributions to the Industry

    Ifergan is actively involved in various boards and committees within the MedTech space, contributing his expertise to guide emerging companies in their growth trajectories. His leadership at Rna Diagnostics and other ventures emphasizes a commitment to improving patient outcomes through advanced medical technologies .14

    Highlights

    Oct 17 · iganpartners.com
    iGan Partners - Leading Global Healthcare Transformation
    iGan Partners - Leading Global Healthcare Transformation
    Aug 15 · lifesciencesbc.ca
    September 7: Venture Capital in Medtech - Life Sciences British ...
    Nov 16 · PR Newswire
    YC and Alchemist-backed Segmed Raises $5.2M Funding Round ... - PR Newswire
    YC and Alchemist-backed Segmed Raises $5.2M Funding Round ... - PR Newswire
    Nov 16 · PR Newswire
    YC and Alchemist-backed Segmed Raises $5.2M Funding Round ... - PR Newswire
    YC and Alchemist-backed Segmed Raises $5.2M Funding Round ... - PR Newswire

    Related Questions

    What are Sam Ifergan's key achievements at iGan Partners?
    How has Sam Ifergan contributed to the growth of RNA Diagnostics?
    What other companies does Sam Ifergan sit on the board of?
    What is the RNA Disruption Assay (RDA) and how does it work?
    What are the future plans for RNA Diagnostics under Sam Ifergan's leadership?
    Sam Ifergan
    Sam Ifergan, photo 1
    Sam Ifergan, photo 2
    Add to my network

    Location

    Greater Toronto Area, Canada